Adenomesenteritis following SARS-CoV-2 Vaccination in Children: A Case Report and Review of The Literature

Adenomesenteritis following SARS-CoV-2 Vaccination in Children: A Case Report and Review of The Literature

At present, the vaccine authorized in children aged 5 years and older is the BNT162b2 messenger RNA COVID-19 vaccine. Unlike adults, there is limited data available in the pediatric age describing adverse events after vaccine. We report a case of adenomesenteritis in a young girl following the first...

Full description

Bibliographic Details
Main Authors: Bloise, S. (Author), Del Giudice, E. (Author), Lubrano, R. (Author), Marcellino, A. (Author), Martucci, V. (Author), Sanseviero, M. (Author), Sermoneta, D. (Author), Spatuzzo, M. (Author), Testa, A. (Author), Ventriglia, F. (Author)
Format: Article
Language:English
Published: MDPI 2022
Subjects:
adverse event
children
lymphadenopathy
SARS-CoV-2
vaccine
Online Access:View Fulltext in Publisher

Similar Items

Similar Items